nodes	percent_of_prediction	percent_of_DWPC	metapath
Fexofenadine—Pimozide—Ezetimibe—coronary artery disease	0.166	0.521	CrCrCtD
Fexofenadine—Fluspirilene—Ezetimibe—coronary artery disease	0.152	0.479	CrCrCtD
Fexofenadine—SLCO1B3—Olmesartan—coronary artery disease	0.0302	0.0559	CbGbCtD
Fexofenadine—SLCO2B1—Pitavastatin—coronary artery disease	0.0272	0.0503	CbGbCtD
Fexofenadine—SLCO1B3—Telmisartan—coronary artery disease	0.0241	0.0447	CbGbCtD
Fexofenadine—SLCO1B3—Pitavastatin—coronary artery disease	0.0241	0.0447	CbGbCtD
Fexofenadine—SLCO2B1—Niacin—coronary artery disease	0.0236	0.0436	CbGbCtD
Fexofenadine—SLCO1B3—Valsartan—coronary artery disease	0.0235	0.0435	CbGbCtD
Fexofenadine—SLCO2B1—Rosuvastatin—coronary artery disease	0.02	0.0371	CbGbCtD
Fexofenadine—SLCO1B1—Gemfibrozil—coronary artery disease	0.0185	0.0344	CbGbCtD
Fexofenadine—SLCO2B1—Pravastatin—coronary artery disease	0.0182	0.0338	CbGbCtD
Fexofenadine—SLCO1B3—Rosuvastatin—coronary artery disease	0.0178	0.033	CbGbCtD
Fexofenadine—SLCO1B1—Olmesartan—coronary artery disease	0.0176	0.0326	CbGbCtD
Fexofenadine—SLCO2B1—Atorvastatin—coronary artery disease	0.0166	0.0307	CbGbCtD
Fexofenadine—SLCO1B3—Pravastatin—coronary artery disease	0.0162	0.03	CbGbCtD
Fexofenadine—SLCO1B3—Atorvastatin—coronary artery disease	0.0147	0.0273	CbGbCtD
Fexofenadine—SLCO1A2—Enalapril—coronary artery disease	0.0141	0.0262	CbGbCtD
Fexofenadine—SLCO1B1—Pitavastatin—coronary artery disease	0.0141	0.026	CbGbCtD
Fexofenadine—SLCO1B1—Valsartan—coronary artery disease	0.0137	0.0253	CbGbCtD
Fexofenadine—SLCO1B3—Losartan—coronary artery disease	0.0135	0.025	CbGbCtD
Fexofenadine—SLCO1A2—Rosuvastatin—coronary artery disease	0.011	0.0203	CbGbCtD
Fexofenadine—SLCO1B1—Ezetimibe—coronary artery disease	0.0104	0.0192	CbGbCtD
Fexofenadine—SLCO1B1—Rosuvastatin—coronary artery disease	0.0104	0.0192	CbGbCtD
Fexofenadine—SLCO1A2—Simvastatin—coronary artery disease	0.0102	0.0189	CbGbCtD
Fexofenadine—SLCO1A2—Lovastatin—coronary artery disease	0.00999	0.0185	CbGbCtD
Fexofenadine—SLCO1A2—Pravastatin—coronary artery disease	0.00999	0.0185	CbGbCtD
Fexofenadine—SLCO1B1—Simvastatin—coronary artery disease	0.00963	0.0178	CbGbCtD
Fexofenadine—SLCO1B1—Lovastatin—coronary artery disease	0.00943	0.0175	CbGbCtD
Fexofenadine—SLCO1B1—Pravastatin—coronary artery disease	0.00943	0.0175	CbGbCtD
Fexofenadine—SLCO1A2—Atorvastatin—coronary artery disease	0.0091	0.0169	CbGbCtD
Fexofenadine—SLCO1B1—Atorvastatin—coronary artery disease	0.00859	0.0159	CbGbCtD
Fexofenadine—SLCO1B1—Losartan—coronary artery disease	0.00785	0.0145	CbGbCtD
Fexofenadine—ABCB1—Ticagrelor—coronary artery disease	0.00746	0.0138	CbGbCtD
Fexofenadine—ABCB1—Clopidogrel—coronary artery disease	0.00461	0.00853	CbGbCtD
Fexofenadine—ABCB1—Perindopril—coronary artery disease	0.00461	0.00853	CbGbCtD
Fexofenadine—ABCB1—Pitavastatin—coronary artery disease	0.00403	0.00746	CbGbCtD
Fexofenadine—ABCB1—Telmisartan—coronary artery disease	0.00403	0.00746	CbGbCtD
Fexofenadine—ABCB1—Enalapril—coronary artery disease	0.00382	0.00707	CbGbCtD
Fexofenadine—ABCB1—Lisinopril—coronary artery disease	0.00382	0.00707	CbGbCtD
Fexofenadine—CYP2D6—Niacin—coronary artery disease	0.00329	0.00609	CbGbCtD
Fexofenadine—ABCB1—Timolol—coronary artery disease	0.00324	0.00601	CbGbCtD
Fexofenadine—CYP2D6—Timolol—coronary artery disease	0.00306	0.00566	CbGbCtD
Fexofenadine—ABCB1—Ezetimibe—coronary artery disease	0.00297	0.0055	CbGbCtD
Fexofenadine—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00289	0.00536	CbGbCtD
Fexofenadine—ABCB1—Captopril—coronary artery disease	0.00286	0.00529	CbGbCtD
Fexofenadine—ABCB1—Simvastatin—coronary artery disease	0.00276	0.00511	CbGbCtD
Fexofenadine—ABCB1—Pravastatin—coronary artery disease	0.0027	0.005	CbGbCtD
Fexofenadine—ABCB1—Lovastatin—coronary artery disease	0.0027	0.005	CbGbCtD
Fexofenadine—CYP2D6—Captopril—coronary artery disease	0.00269	0.00499	CbGbCtD
Fexofenadine—CYP2D6—Simvastatin—coronary artery disease	0.0026	0.00482	CbGbCtD
Fexofenadine—CYP2D6—Lovastatin—coronary artery disease	0.00254	0.00471	CbGbCtD
Fexofenadine—CYP2D6—Pravastatin—coronary artery disease	0.00254	0.00471	CbGbCtD
Fexofenadine—ABCB1—Atorvastatin—coronary artery disease	0.00246	0.00456	CbGbCtD
Fexofenadine—CYP2D6—Atorvastatin—coronary artery disease	0.00232	0.00429	CbGbCtD
Fexofenadine—ABCB1—Losartan—coronary artery disease	0.00225	0.00417	CbGbCtD
Fexofenadine—Diphenoxylate—OPRD1—coronary artery disease	0.000445	0.254	CrCbGaD
Fexofenadine—Loperamide—POMC—coronary artery disease	0.000328	0.187	CrCbGaD
Fexofenadine—Fentanyl—OPRD1—coronary artery disease	0.000192	0.109	CrCbGaD
Fexofenadine—Loperamide—OPRD1—coronary artery disease	0.000184	0.105	CrCbGaD
Fexofenadine—Fluspirilene—ADRB1—coronary artery disease	0.000163	0.0932	CrCbGaD
Fexofenadine—Methadone—OPRD1—coronary artery disease	0.000131	0.075	CrCbGaD
Fexofenadine—Fluspirilene—HTR2A—coronary artery disease	9.58e-05	0.0547	CrCbGaD
Fexofenadine—Pimozide—CYP2C19—coronary artery disease	8.83e-05	0.0504	CrCbGaD
Fexofenadine—Body temperature increased—Trandolapril—coronary artery disease	8e-05	0.000755	CcSEcCtD
Fexofenadine—Abdominal pain—Trandolapril—coronary artery disease	8e-05	0.000755	CcSEcCtD
Fexofenadine—Dizziness—Ezetimibe—coronary artery disease	8e-05	0.000754	CcSEcCtD
Fexofenadine—Palpitations—Timolol—coronary artery disease	8e-05	0.000754	CcSEcCtD
Fexofenadine—Abdominal pain—Enalapril—coronary artery disease	7.97e-05	0.000751	CcSEcCtD
Fexofenadine—Body temperature increased—Enalapril—coronary artery disease	7.97e-05	0.000751	CcSEcCtD
Fexofenadine—Insomnia—Losartan—coronary artery disease	7.97e-05	0.000751	CcSEcCtD
Fexofenadine—Rash—Fenofibrate—coronary artery disease	7.96e-05	0.000751	CcSEcCtD
Fexofenadine—Dermatitis—Fenofibrate—coronary artery disease	7.96e-05	0.00075	CcSEcCtD
Fexofenadine—Headache—Fenofibrate—coronary artery disease	7.91e-05	0.000746	CcSEcCtD
Fexofenadine—Vision blurred—Lisinopril—coronary artery disease	7.91e-05	0.000746	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Captopril—coronary artery disease	7.91e-05	0.000746	CcSEcCtD
Fexofenadine—Urticaria—Telmisartan—coronary artery disease	7.9e-05	0.000745	CcSEcCtD
Fexofenadine—Cough—Timolol—coronary artery disease	7.9e-05	0.000744	CcSEcCtD
Fexofenadine—Vomiting—Clopidogrel—coronary artery disease	7.89e-05	0.000744	CcSEcCtD
Fexofenadine—Diarrhoea—Simvastatin—coronary artery disease	7.89e-05	0.000744	CcSEcCtD
Fexofenadine—Myalgia—Ramipril—coronary artery disease	7.88e-05	0.000743	CcSEcCtD
Fexofenadine—Fatigue—Furosemide—coronary artery disease	7.87e-05	0.000742	CcSEcCtD
Fexofenadine—Body temperature increased—Telmisartan—coronary artery disease	7.86e-05	0.000741	CcSEcCtD
Fexofenadine—Abdominal pain—Telmisartan—coronary artery disease	7.86e-05	0.000741	CcSEcCtD
Fexofenadine—Dyspnoea—Losartan—coronary artery disease	7.85e-05	0.00074	CcSEcCtD
Fexofenadine—Vomiting—Lovastatin—coronary artery disease	7.84e-05	0.000739	CcSEcCtD
Fexofenadine—Somnolence—Losartan—coronary artery disease	7.83e-05	0.000738	CcSEcCtD
Fexofenadine—Dizziness—Eplerenone—coronary artery disease	7.83e-05	0.000738	CcSEcCtD
Fexofenadine—Rash—Clopidogrel—coronary artery disease	7.83e-05	0.000738	CcSEcCtD
Fexofenadine—Dermatitis—Clopidogrel—coronary artery disease	7.82e-05	0.000737	CcSEcCtD
Fexofenadine—Asthenia—Valsartan—coronary artery disease	7.82e-05	0.000737	CcSEcCtD
Fexofenadine—Pain—Furosemide—coronary artery disease	7.81e-05	0.000736	CcSEcCtD
Fexofenadine—Hypersensitivity—Niacin—coronary artery disease	7.8e-05	0.000735	CcSEcCtD
Fexofenadine—Asthenia—Olmesartan—coronary artery disease	7.78e-05	0.000733	CcSEcCtD
Fexofenadine—Headache—Clopidogrel—coronary artery disease	7.78e-05	0.000733	CcSEcCtD
Fexofenadine—Rash—Lovastatin—coronary artery disease	7.77e-05	0.000733	CcSEcCtD
Fexofenadine—Dermatitis—Lovastatin—coronary artery disease	7.77e-05	0.000732	CcSEcCtD
Fexofenadine—Dyspepsia—Losartan—coronary artery disease	7.75e-05	0.000731	CcSEcCtD
Fexofenadine—Headache—Lovastatin—coronary artery disease	7.72e-05	0.000728	CcSEcCtD
Fexofenadine—Pruritus—Valsartan—coronary artery disease	7.71e-05	0.000726	CcSEcCtD
Fexofenadine—Dry mouth—Ramipril—coronary artery disease	7.71e-05	0.000726	CcSEcCtD
Fexofenadine—Myalgia—Timolol—coronary artery disease	7.7e-05	0.000726	CcSEcCtD
Fexofenadine—Vomiting—Ezetimibe—coronary artery disease	7.69e-05	0.000725	CcSEcCtD
Fexofenadine—Hypersensitivity—Pravastatin—coronary artery disease	7.68e-05	0.000724	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Perindopril—coronary artery disease	7.68e-05	0.000724	CcSEcCtD
Fexofenadine—Angioedema—Lisinopril—coronary artery disease	7.67e-05	0.000723	CcSEcCtD
Fexofenadine—Pruritus—Olmesartan—coronary artery disease	7.67e-05	0.000723	CcSEcCtD
Fexofenadine—Body temperature increased—Captopril—coronary artery disease	7.65e-05	0.000721	CcSEcCtD
Fexofenadine—Abdominal pain—Captopril—coronary artery disease	7.65e-05	0.000721	CcSEcCtD
Fexofenadine—Dizziness—Simvastatin—coronary artery disease	7.63e-05	0.000719	CcSEcCtD
Fexofenadine—Rash—Ezetimibe—coronary artery disease	7.63e-05	0.000719	CcSEcCtD
Fexofenadine—Dermatitis—Ezetimibe—coronary artery disease	7.62e-05	0.000718	CcSEcCtD
Fexofenadine—Asthenia—Niacin—coronary artery disease	7.6e-05	0.000716	CcSEcCtD
Fexofenadine—Fatigue—Losartan—coronary artery disease	7.59e-05	0.000716	CcSEcCtD
Fexofenadine—Headache—Ezetimibe—coronary artery disease	7.58e-05	0.000714	CcSEcCtD
Fexofenadine—Anaphylactic shock—Ramipril—coronary artery disease	7.55e-05	0.000712	CcSEcCtD
Fexofenadine—Dry mouth—Timolol—coronary artery disease	7.53e-05	0.00071	CcSEcCtD
Fexofenadine—Pain—Losartan—coronary artery disease	7.53e-05	0.00071	CcSEcCtD
Fexofenadine—Vomiting—Eplerenone—coronary artery disease	7.53e-05	0.000709	CcSEcCtD
Fexofenadine—Nausea—Fenofibrate—coronary artery disease	7.5e-05	0.000707	CcSEcCtD
Fexofenadine—Pruritus—Niacin—coronary artery disease	7.49e-05	0.000706	CcSEcCtD
Fexofenadine—Asthenia—Pravastatin—coronary artery disease	7.48e-05	0.000705	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Furosemide—coronary artery disease	7.47e-05	0.000704	CcSEcCtD
Fexofenadine—Rash—Eplerenone—coronary artery disease	7.46e-05	0.000704	CcSEcCtD
Fexofenadine—Urticaria—Perindopril—coronary artery disease	7.46e-05	0.000703	CcSEcCtD
Fexofenadine—Hypersensitivity—Trandolapril—coronary artery disease	7.46e-05	0.000703	CcSEcCtD
Fexofenadine—Dermatitis—Eplerenone—coronary artery disease	7.46e-05	0.000703	CcSEcCtD
Fexofenadine—Diarrhoea—Valsartan—coronary artery disease	7.45e-05	0.000702	CcSEcCtD
Fexofenadine—Hypersensitivity—Enalapril—coronary artery disease	7.43e-05	0.0007	CcSEcCtD
Fexofenadine—Abdominal pain—Perindopril—coronary artery disease	7.42e-05	0.0007	CcSEcCtD
Fexofenadine—Body temperature increased—Perindopril—coronary artery disease	7.42e-05	0.0007	CcSEcCtD
Fexofenadine—Palpitations—Lisinopril—coronary artery disease	7.42e-05	0.000699	CcSEcCtD
Fexofenadine—Diarrhoea—Olmesartan—coronary artery disease	7.42e-05	0.000699	CcSEcCtD
Fexofenadine—Headache—Eplerenone—coronary artery disease	7.42e-05	0.000699	CcSEcCtD
Fexofenadine—Anaphylactic shock—Timolol—coronary artery disease	7.38e-05	0.000696	CcSEcCtD
Fexofenadine—Pruritus—Pravastatin—coronary artery disease	7.38e-05	0.000695	CcSEcCtD
Fexofenadine—Nausea—Clopidogrel—coronary artery disease	7.37e-05	0.000695	CcSEcCtD
Fexofenadine—Tachycardia—Ramipril—coronary artery disease	7.37e-05	0.000695	CcSEcCtD
Fexofenadine—Infection—Timolol—coronary artery disease	7.34e-05	0.000691	CcSEcCtD
Fexofenadine—Vomiting—Simvastatin—coronary artery disease	7.33e-05	0.000691	CcSEcCtD
Fexofenadine—Hypersensitivity—Telmisartan—coronary artery disease	7.33e-05	0.000691	CcSEcCtD
Fexofenadine—Cough—Lisinopril—coronary artery disease	7.32e-05	0.00069	CcSEcCtD
Fexofenadine—Nausea—Lovastatin—coronary artery disease	7.32e-05	0.00069	CcSEcCtD
Fexofenadine—Rash—Simvastatin—coronary artery disease	7.27e-05	0.000685	CcSEcCtD
Fexofenadine—Dermatitis—Simvastatin—coronary artery disease	7.27e-05	0.000685	CcSEcCtD
Fexofenadine—Asthenia—Trandolapril—coronary artery disease	7.27e-05	0.000685	CcSEcCtD
Fexofenadine—Urticaria—Furosemide—coronary artery disease	7.25e-05	0.000684	CcSEcCtD
Fexofenadine—Diarrhoea—Niacin—coronary artery disease	7.25e-05	0.000683	CcSEcCtD
Fexofenadine—Asthenia—Enalapril—coronary artery disease	7.24e-05	0.000682	CcSEcCtD
Fexofenadine—Headache—Simvastatin—coronary artery disease	7.23e-05	0.000681	CcSEcCtD
Fexofenadine—Abdominal pain—Furosemide—coronary artery disease	7.22e-05	0.00068	CcSEcCtD
Fexofenadine—Body temperature increased—Furosemide—coronary artery disease	7.22e-05	0.00068	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Losartan—coronary artery disease	7.2e-05	0.000679	CcSEcCtD
Fexofenadine—Dizziness—Valsartan—coronary artery disease	7.2e-05	0.000679	CcSEcCtD
Fexofenadine—Nausea—Ezetimibe—coronary artery disease	7.18e-05	0.000677	CcSEcCtD
Fexofenadine—Dizziness—Olmesartan—coronary artery disease	7.17e-05	0.000676	CcSEcCtD
Fexofenadine—Pruritus—Trandolapril—coronary artery disease	7.16e-05	0.000675	CcSEcCtD
Fexofenadine—Pimozide—HTR2A—coronary artery disease	7.16e-05	0.0409	CrCbGaD
Fexofenadine—Myalgia—Lisinopril—coronary artery disease	7.15e-05	0.000674	CcSEcCtD
Fexofenadine—Asthenia—Telmisartan—coronary artery disease	7.14e-05	0.000673	CcSEcCtD
Fexofenadine—Pruritus—Enalapril—coronary artery disease	7.14e-05	0.000673	CcSEcCtD
Fexofenadine—Diarrhoea—Pravastatin—coronary artery disease	7.13e-05	0.000672	CcSEcCtD
Fexofenadine—Pruritus—Telmisartan—coronary artery disease	7.04e-05	0.000663	CcSEcCtD
Fexofenadine—Nausea—Eplerenone—coronary artery disease	7.03e-05	0.000663	CcSEcCtD
Fexofenadine—Dizziness—Niacin—coronary artery disease	7e-05	0.00066	CcSEcCtD
Fexofenadine—Urticaria—Losartan—coronary artery disease	7e-05	0.00066	CcSEcCtD
Fexofenadine—Dry mouth—Lisinopril—coronary artery disease	6.99e-05	0.000659	CcSEcCtD
Fexofenadine—Abdominal pain—Losartan—coronary artery disease	6.96e-05	0.000656	CcSEcCtD
Fexofenadine—Body temperature increased—Losartan—coronary artery disease	6.96e-05	0.000656	CcSEcCtD
Fexofenadine—Asthenia—Captopril—coronary artery disease	6.94e-05	0.000654	CcSEcCtD
Fexofenadine—Diarrhoea—Trandolapril—coronary artery disease	6.93e-05	0.000653	CcSEcCtD
Fexofenadine—Vomiting—Valsartan—coronary artery disease	6.93e-05	0.000653	CcSEcCtD
Fexofenadine—Diarrhoea—Enalapril—coronary artery disease	6.9e-05	0.00065	CcSEcCtD
Fexofenadine—Dizziness—Pravastatin—coronary artery disease	6.9e-05	0.00065	CcSEcCtD
Fexofenadine—Vomiting—Olmesartan—coronary artery disease	6.89e-05	0.00065	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Ramipril—coronary artery disease	6.88e-05	0.000649	CcSEcCtD
Fexofenadine—Rash—Valsartan—coronary artery disease	6.87e-05	0.000647	CcSEcCtD
Fexofenadine—Dermatitis—Valsartan—coronary artery disease	6.86e-05	0.000647	CcSEcCtD
Fexofenadine—Nausea—Simvastatin—coronary artery disease	6.85e-05	0.000646	CcSEcCtD
Fexofenadine—Anaphylactic shock—Lisinopril—coronary artery disease	6.85e-05	0.000646	CcSEcCtD
Fexofenadine—Pruritus—Captopril—coronary artery disease	6.84e-05	0.000645	CcSEcCtD
Fexofenadine—Rash—Olmesartan—coronary artery disease	6.83e-05	0.000644	CcSEcCtD
Fexofenadine—Insomnia—Ramipril—coronary artery disease	6.83e-05	0.000644	CcSEcCtD
Fexofenadine—Dermatitis—Olmesartan—coronary artery disease	6.83e-05	0.000644	CcSEcCtD
Fexofenadine—Headache—Valsartan—coronary artery disease	6.82e-05	0.000643	CcSEcCtD
Fexofenadine—Diarrhoea—Telmisartan—coronary artery disease	6.81e-05	0.000642	CcSEcCtD
Fexofenadine—Infection—Lisinopril—coronary artery disease	6.81e-05	0.000641	CcSEcCtD
Fexofenadine—Headache—Olmesartan—coronary artery disease	6.79e-05	0.00064	CcSEcCtD
Fexofenadine—Asthenia—Perindopril—coronary artery disease	6.74e-05	0.000635	CcSEcCtD
Fexofenadine—Dyspnoea—Ramipril—coronary artery disease	6.73e-05	0.000635	CcSEcCtD
Fexofenadine—Vomiting—Niacin—coronary artery disease	6.73e-05	0.000635	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Timolol—coronary artery disease	6.73e-05	0.000634	CcSEcCtD
Fexofenadine—Hypersensitivity—Furosemide—coronary artery disease	6.73e-05	0.000634	CcSEcCtD
Fexofenadine—Somnolence—Ramipril—coronary artery disease	6.72e-05	0.000633	CcSEcCtD
Fexofenadine—Dizziness—Trandolapril—coronary artery disease	6.7e-05	0.000631	CcSEcCtD
Fexofenadine—Tachycardia—Lisinopril—coronary artery disease	6.69e-05	0.00063	CcSEcCtD
Fexofenadine—Insomnia—Timolol—coronary artery disease	6.68e-05	0.00063	CcSEcCtD
Fexofenadine—Rash—Niacin—coronary artery disease	6.68e-05	0.000629	CcSEcCtD
Fexofenadine—Dermatitis—Niacin—coronary artery disease	6.67e-05	0.000629	CcSEcCtD
Fexofenadine—Dizziness—Enalapril—coronary artery disease	6.67e-05	0.000629	CcSEcCtD
Fexofenadine—Dyspepsia—Ramipril—coronary artery disease	6.65e-05	0.000627	CcSEcCtD
Fexofenadine—Pruritus—Perindopril—coronary artery disease	6.64e-05	0.000626	CcSEcCtD
Fexofenadine—Headache—Niacin—coronary artery disease	6.63e-05	0.000625	CcSEcCtD
Fexofenadine—Vomiting—Pravastatin—coronary artery disease	6.63e-05	0.000625	CcSEcCtD
Fexofenadine—Diarrhoea—Captopril—coronary artery disease	6.62e-05	0.000624	CcSEcCtD
Fexofenadine—Dyspnoea—Timolol—coronary artery disease	6.58e-05	0.000621	CcSEcCtD
Fexofenadine—Dizziness—Telmisartan—coronary artery disease	6.58e-05	0.00062	CcSEcCtD
Fexofenadine—Rash—Pravastatin—coronary artery disease	6.57e-05	0.00062	CcSEcCtD
Fexofenadine—Dermatitis—Pravastatin—coronary artery disease	6.57e-05	0.000619	CcSEcCtD
Fexofenadine—Somnolence—Timolol—coronary artery disease	6.56e-05	0.000619	CcSEcCtD
Fexofenadine—Asthenia—Furosemide—coronary artery disease	6.55e-05	0.000617	CcSEcCtD
Fexofenadine—Headache—Pravastatin—coronary artery disease	6.53e-05	0.000616	CcSEcCtD
Fexofenadine—Fatigue—Ramipril—coronary artery disease	6.51e-05	0.000614	CcSEcCtD
Fexofenadine—Dyspepsia—Timolol—coronary artery disease	6.5e-05	0.000613	CcSEcCtD
Fexofenadine—Hypersensitivity—Losartan—coronary artery disease	6.49e-05	0.000612	CcSEcCtD
Fexofenadine—Nausea—Valsartan—coronary artery disease	6.47e-05	0.00061	CcSEcCtD
Fexofenadine—Pruritus—Furosemide—coronary artery disease	6.46e-05	0.000609	CcSEcCtD
Fexofenadine—Nausea—Olmesartan—coronary artery disease	6.44e-05	0.000607	CcSEcCtD
Fexofenadine—Vomiting—Trandolapril—coronary artery disease	6.44e-05	0.000607	CcSEcCtD
Fexofenadine—Diarrhoea—Perindopril—coronary artery disease	6.43e-05	0.000606	CcSEcCtD
Fexofenadine—Vomiting—Enalapril—coronary artery disease	6.41e-05	0.000604	CcSEcCtD
Fexofenadine—Dizziness—Captopril—coronary artery disease	6.4e-05	0.000603	CcSEcCtD
Fexofenadine—Rash—Trandolapril—coronary artery disease	6.38e-05	0.000602	CcSEcCtD
Fexofenadine—Dermatitis—Trandolapril—coronary artery disease	6.38e-05	0.000601	CcSEcCtD
Fexofenadine—Fatigue—Timolol—coronary artery disease	6.37e-05	0.0006	CcSEcCtD
Fexofenadine—Rash—Enalapril—coronary artery disease	6.36e-05	0.000599	CcSEcCtD
Fexofenadine—Dermatitis—Enalapril—coronary artery disease	6.35e-05	0.000599	CcSEcCtD
Fexofenadine—Headache—Trandolapril—coronary artery disease	6.34e-05	0.000598	CcSEcCtD
Fexofenadine—Vomiting—Telmisartan—coronary artery disease	6.32e-05	0.000596	CcSEcCtD
Fexofenadine—Asthenia—Losartan—coronary artery disease	6.32e-05	0.000596	CcSEcCtD
Fexofenadine—Headache—Enalapril—coronary artery disease	6.32e-05	0.000596	CcSEcCtD
Fexofenadine—Pain—Timolol—coronary artery disease	6.31e-05	0.000595	CcSEcCtD
Fexofenadine—Nausea—Niacin—coronary artery disease	6.29e-05	0.000593	CcSEcCtD
Fexofenadine—Rash—Telmisartan—coronary artery disease	6.27e-05	0.000591	CcSEcCtD
Fexofenadine—Dermatitis—Telmisartan—coronary artery disease	6.27e-05	0.000591	CcSEcCtD
Fexofenadine—Diarrhoea—Furosemide—coronary artery disease	6.25e-05	0.000589	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Lisinopril—coronary artery disease	6.24e-05	0.000588	CcSEcCtD
Fexofenadine—Pruritus—Losartan—coronary artery disease	6.23e-05	0.000587	CcSEcCtD
Fexofenadine—Headache—Telmisartan—coronary artery disease	6.23e-05	0.000587	CcSEcCtD
Fexofenadine—Dizziness—Perindopril—coronary artery disease	6.21e-05	0.000585	CcSEcCtD
Fexofenadine—Insomnia—Lisinopril—coronary artery disease	6.2e-05	0.000584	CcSEcCtD
Fexofenadine—Nausea—Pravastatin—coronary artery disease	6.19e-05	0.000584	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Ramipril—coronary artery disease	6.18e-05	0.000582	CcSEcCtD
Fexofenadine—Vomiting—Captopril—coronary artery disease	6.15e-05	0.00058	CcSEcCtD
Fexofenadine—Dyspnoea—Lisinopril—coronary artery disease	6.11e-05	0.000576	CcSEcCtD
Fexofenadine—Rash—Captopril—coronary artery disease	6.1e-05	0.000575	CcSEcCtD
Fexofenadine—Dermatitis—Captopril—coronary artery disease	6.09e-05	0.000574	CcSEcCtD
Fexofenadine—Somnolence—Lisinopril—coronary artery disease	6.09e-05	0.000574	CcSEcCtD
Fexofenadine—Headache—Captopril—coronary artery disease	6.06e-05	0.000571	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Timolol—coronary artery disease	6.04e-05	0.000569	CcSEcCtD
Fexofenadine—Dizziness—Furosemide—coronary artery disease	6.04e-05	0.000569	CcSEcCtD
Fexofenadine—Dyspepsia—Lisinopril—coronary artery disease	6.03e-05	0.000568	CcSEcCtD
Fexofenadine—Diarrhoea—Losartan—coronary artery disease	6.03e-05	0.000568	CcSEcCtD
Fexofenadine—Nausea—Trandolapril—coronary artery disease	6.01e-05	0.000567	CcSEcCtD
Fexofenadine—Urticaria—Ramipril—coronary artery disease	6e-05	0.000566	CcSEcCtD
Fexofenadine—Nausea—Enalapril—coronary artery disease	5.99e-05	0.000565	CcSEcCtD
Fexofenadine—Vomiting—Perindopril—coronary artery disease	5.97e-05	0.000563	CcSEcCtD
Fexofenadine—Abdominal pain—Ramipril—coronary artery disease	5.97e-05	0.000563	CcSEcCtD
Fexofenadine—Body temperature increased—Ramipril—coronary artery disease	5.97e-05	0.000563	CcSEcCtD
Fexofenadine—Rash—Perindopril—coronary artery disease	5.92e-05	0.000558	CcSEcCtD
Fexofenadine—Dermatitis—Perindopril—coronary artery disease	5.92e-05	0.000558	CcSEcCtD
Fexofenadine—Nausea—Telmisartan—coronary artery disease	5.91e-05	0.000557	CcSEcCtD
Fexofenadine—Fatigue—Lisinopril—coronary artery disease	5.91e-05	0.000557	CcSEcCtD
Fexofenadine—Headache—Perindopril—coronary artery disease	5.88e-05	0.000555	CcSEcCtD
Fexofenadine—Urticaria—Timolol—coronary artery disease	5.87e-05	0.000553	CcSEcCtD
Fexofenadine—Pain—Lisinopril—coronary artery disease	5.86e-05	0.000552	CcSEcCtD
Fexofenadine—Abdominal pain—Timolol—coronary artery disease	5.84e-05	0.00055	CcSEcCtD
Fexofenadine—Body temperature increased—Timolol—coronary artery disease	5.84e-05	0.00055	CcSEcCtD
Fexofenadine—Dizziness—Losartan—coronary artery disease	5.83e-05	0.000549	CcSEcCtD
Fexofenadine—Vomiting—Furosemide—coronary artery disease	5.81e-05	0.000547	CcSEcCtD
Fexofenadine—Rash—Furosemide—coronary artery disease	5.76e-05	0.000543	CcSEcCtD
Fexofenadine—Dermatitis—Furosemide—coronary artery disease	5.75e-05	0.000542	CcSEcCtD
Fexofenadine—Nausea—Captopril—coronary artery disease	5.75e-05	0.000542	CcSEcCtD
Fexofenadine—Headache—Furosemide—coronary artery disease	5.72e-05	0.000539	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Lisinopril—coronary artery disease	5.6e-05	0.000528	CcSEcCtD
Fexofenadine—Vomiting—Losartan—coronary artery disease	5.6e-05	0.000528	CcSEcCtD
Fexofenadine—Nausea—Perindopril—coronary artery disease	5.58e-05	0.000526	CcSEcCtD
Fexofenadine—Hypersensitivity—Ramipril—coronary artery disease	5.57e-05	0.000525	CcSEcCtD
Fexofenadine—Rash—Losartan—coronary artery disease	5.55e-05	0.000524	CcSEcCtD
Fexofenadine—Dermatitis—Losartan—coronary artery disease	5.55e-05	0.000523	CcSEcCtD
Fexofenadine—Headache—Losartan—coronary artery disease	5.52e-05	0.00052	CcSEcCtD
Fexofenadine—Urticaria—Lisinopril—coronary artery disease	5.44e-05	0.000513	CcSEcCtD
Fexofenadine—Hypersensitivity—Timolol—coronary artery disease	5.44e-05	0.000513	CcSEcCtD
Fexofenadine—Nausea—Furosemide—coronary artery disease	5.42e-05	0.000511	CcSEcCtD
Fexofenadine—Asthenia—Ramipril—coronary artery disease	5.42e-05	0.000511	CcSEcCtD
Fexofenadine—Abdominal pain—Lisinopril—coronary artery disease	5.42e-05	0.00051	CcSEcCtD
Fexofenadine—Body temperature increased—Lisinopril—coronary artery disease	5.42e-05	0.00051	CcSEcCtD
Fexofenadine—Pruritus—Ramipril—coronary artery disease	5.34e-05	0.000504	CcSEcCtD
Fexofenadine—Asthenia—Timolol—coronary artery disease	5.3e-05	0.000499	CcSEcCtD
Fexofenadine—Methadone—CYP2C19—coronary artery disease	5.25e-05	0.03	CrCbGaD
Fexofenadine—Nausea—Losartan—coronary artery disease	5.23e-05	0.000493	CcSEcCtD
Fexofenadine—Pruritus—Timolol—coronary artery disease	5.22e-05	0.000492	CcSEcCtD
Fexofenadine—Diarrhoea—Ramipril—coronary artery disease	5.17e-05	0.000487	CcSEcCtD
Fexofenadine—Diarrhoea—Timolol—coronary artery disease	5.05e-05	0.000476	CcSEcCtD
Fexofenadine—Hypersensitivity—Lisinopril—coronary artery disease	5.05e-05	0.000476	CcSEcCtD
Fexofenadine—Dizziness—Ramipril—coronary artery disease	5e-05	0.000471	CcSEcCtD
Fexofenadine—Asthenia—Lisinopril—coronary artery disease	4.92e-05	0.000463	CcSEcCtD
Fexofenadine—Dizziness—Timolol—coronary artery disease	4.88e-05	0.00046	CcSEcCtD
Fexofenadine—Pruritus—Lisinopril—coronary artery disease	4.85e-05	0.000457	CcSEcCtD
Fexofenadine—Vomiting—Ramipril—coronary artery disease	4.8e-05	0.000453	CcSEcCtD
Fexofenadine—Rash—Ramipril—coronary artery disease	4.76e-05	0.000449	CcSEcCtD
Fexofenadine—Dermatitis—Ramipril—coronary artery disease	4.76e-05	0.000448	CcSEcCtD
Fexofenadine—Headache—Ramipril—coronary artery disease	4.73e-05	0.000446	CcSEcCtD
Fexofenadine—Vomiting—Timolol—coronary artery disease	4.7e-05	0.000443	CcSEcCtD
Fexofenadine—Diarrhoea—Lisinopril—coronary artery disease	4.69e-05	0.000442	CcSEcCtD
Fexofenadine—Rash—Timolol—coronary artery disease	4.66e-05	0.000439	CcSEcCtD
Fexofenadine—Dermatitis—Timolol—coronary artery disease	4.65e-05	0.000438	CcSEcCtD
Fexofenadine—Headache—Timolol—coronary artery disease	4.63e-05	0.000436	CcSEcCtD
Fexofenadine—Dizziness—Lisinopril—coronary artery disease	4.53e-05	0.000427	CcSEcCtD
Fexofenadine—Nausea—Ramipril—coronary artery disease	4.49e-05	0.000423	CcSEcCtD
Fexofenadine—Nausea—Timolol—coronary artery disease	4.39e-05	0.000413	CcSEcCtD
Fexofenadine—Vomiting—Lisinopril—coronary artery disease	4.36e-05	0.000411	CcSEcCtD
Fexofenadine—Rash—Lisinopril—coronary artery disease	4.32e-05	0.000407	CcSEcCtD
Fexofenadine—Dermatitis—Lisinopril—coronary artery disease	4.32e-05	0.000407	CcSEcCtD
Fexofenadine—Headache—Lisinopril—coronary artery disease	4.29e-05	0.000405	CcSEcCtD
Fexofenadine—Nausea—Lisinopril—coronary artery disease	4.07e-05	0.000384	CcSEcCtD
Fexofenadine—HRH1—Signaling Pathways—CCL3—coronary artery disease	5.15e-06	0.000152	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CXCL2—coronary artery disease	5.15e-06	0.000152	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—APOB—coronary artery disease	5.14e-06	0.000152	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GSTA1—coronary artery disease	5.13e-06	0.000151	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—coronary artery disease	5.13e-06	0.000151	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—F2R—coronary artery disease	5.1e-06	0.00015	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SDC1—coronary artery disease	5.1e-06	0.00015	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PRKCD—coronary artery disease	5.09e-06	0.00015	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—LPA—coronary artery disease	5.07e-06	0.000149	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PLA2G2A—coronary artery disease	5.01e-06	0.000148	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GPX2—coronary artery disease	5.01e-06	0.000148	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—APOA2—coronary artery disease	5.01e-06	0.000148	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—GSTM1—coronary artery disease	5e-06	0.000147	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—FGB—coronary artery disease	4.99e-06	0.000147	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—HTR2A—coronary artery disease	4.98e-06	0.000147	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—C3—coronary artery disease	4.97e-06	0.000146	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—SULT1A1—coronary artery disease	4.95e-06	0.000146	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—HK1—coronary artery disease	4.95e-06	0.000146	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GPX4—coronary artery disease	4.95e-06	0.000146	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ABCG5—coronary artery disease	4.95e-06	0.000146	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—EDNRB—coronary artery disease	4.94e-06	0.000145	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—AGT—coronary artery disease	4.91e-06	0.000145	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PLCB3—coronary artery disease	4.91e-06	0.000145	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—LPL—coronary artery disease	4.91e-06	0.000145	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—HADHA—coronary artery disease	4.89e-06	0.000144	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—THBS1—coronary artery disease	4.86e-06	0.000143	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—APOA5—coronary artery disease	4.86e-06	0.000143	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GSTA1—coronary artery disease	4.83e-06	0.000142	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PSMB5—coronary artery disease	4.82e-06	0.000142	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PSMA6—coronary artery disease	4.82e-06	0.000142	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—APOE—coronary artery disease	4.81e-06	0.000142	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—F2—coronary artery disease	4.8e-06	0.000142	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—ALB—coronary artery disease	4.8e-06	0.000141	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—GPX1—coronary artery disease	4.79e-06	0.000141	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—LPA—coronary artery disease	4.78e-06	0.000141	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—P4HB—coronary artery disease	4.77e-06	0.000141	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—APOA1—coronary artery disease	4.76e-06	0.00014	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—AGT—coronary artery disease	4.72e-06	0.000139	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PLA2G1B—coronary artery disease	4.68e-06	0.000138	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—coronary artery disease	4.67e-06	0.000138	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—CD36—coronary artery disease	4.67e-06	0.000138	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—EDNRA—coronary artery disease	4.66e-06	0.000137	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CYBA—coronary artery disease	4.64e-06	0.000137	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ADRB1—coronary artery disease	4.64e-06	0.000137	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PLCB3—coronary artery disease	4.63e-06	0.000136	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—DUSP6—coronary artery disease	4.62e-06	0.000136	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PPP2CA—coronary artery disease	4.61e-06	0.000136	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—NOS3—coronary artery disease	4.59e-06	0.000135	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—APOA5—coronary artery disease	4.58e-06	0.000135	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	4.56e-06	0.000134	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PLAT—coronary artery disease	4.54e-06	0.000134	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—P4HB—coronary artery disease	4.49e-06	0.000132	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—MTHFR—coronary artery disease	4.42e-06	0.00013	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—VCAN—coronary artery disease	4.41e-06	0.00013	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PLA2G1B—coronary artery disease	4.41e-06	0.00013	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—BDKRB2—coronary artery disease	4.38e-06	0.000129	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CXCL12—coronary artery disease	4.38e-06	0.000129	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ALDOA—coronary artery disease	4.38e-06	0.000129	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—POMC—coronary artery disease	4.38e-06	0.000129	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—F2—coronary artery disease	4.36e-06	0.000129	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—APOA1—coronary artery disease	4.35e-06	0.000128	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—IL6ST—coronary artery disease	4.35e-06	0.000128	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—JUNB—coronary artery disease	4.3e-06	0.000127	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PLCB1—coronary artery disease	4.29e-06	0.000126	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—DCN—coronary artery disease	4.25e-06	0.000125	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—AGT—coronary artery disease	4.2e-06	0.000124	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PTGS2—coronary artery disease	4.2e-06	0.000124	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—HTR7—coronary artery disease	4.2e-06	0.000124	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PPARG—coronary artery disease	4.19e-06	0.000124	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—VCAN—coronary artery disease	4.16e-06	0.000123	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—POMC—coronary artery disease	4.14e-06	0.000122	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ALDH2—coronary artery disease	4.13e-06	0.000122	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ALDOA—coronary artery disease	4.12e-06	0.000122	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—APOE—coronary artery disease	4.12e-06	0.000121	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—APOA1—coronary artery disease	4.07e-06	0.00012	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—HBA1—coronary artery disease	4.03e-06	0.000119	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PIK3C2A—coronary artery disease	4.03e-06	0.000119	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—LIPC—coronary artery disease	4.03e-06	0.000119	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CYP2C19—coronary artery disease	4.03e-06	0.000119	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—DCN—coronary artery disease	4e-06	0.000118	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—APOC3—coronary artery disease	4e-06	0.000118	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ITGAV—coronary artery disease	4e-06	0.000118	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—KNG1—coronary artery disease	3.99e-06	0.000118	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—LDLR—coronary artery disease	3.98e-06	0.000117	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—POMC—coronary artery disease	3.97e-06	0.000117	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—CREB1—coronary artery disease	3.97e-06	0.000117	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—AGTR1—coronary artery disease	3.96e-06	0.000117	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GSTT1—coronary artery disease	3.93e-06	0.000116	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—SLC9A1—coronary artery disease	3.93e-06	0.000116	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	3.9e-06	0.000115	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ALDH2—coronary artery disease	3.9e-06	0.000115	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—CCL2—coronary artery disease	3.89e-06	0.000115	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GCLC—coronary artery disease	3.89e-06	0.000115	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CETP—coronary artery disease	3.89e-06	0.000115	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—IL6R—coronary artery disease	3.88e-06	0.000114	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CXCL10—coronary artery disease	3.87e-06	0.000114	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PLG—coronary artery disease	3.86e-06	0.000114	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—SDC1—coronary artery disease	3.84e-06	0.000113	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—coronary artery disease	3.82e-06	0.000112	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CYP2C19—coronary artery disease	3.8e-06	0.000112	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—LIPC—coronary artery disease	3.8e-06	0.000112	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—HBA1—coronary artery disease	3.8e-06	0.000112	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PIK3C2A—coronary artery disease	3.8e-06	0.000112	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—APOC3—coronary artery disease	3.77e-06	0.000111	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—ALB—coronary artery disease	3.77e-06	0.000111	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ADRB2—coronary artery disease	3.76e-06	0.000111	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—LDLR—coronary artery disease	3.75e-06	0.000111	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PRKCE—coronary artery disease	3.71e-06	0.000109	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—JAK2—coronary artery disease	3.71e-06	0.000109	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GSTT1—coronary artery disease	3.71e-06	0.000109	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—SLC9A1—coronary artery disease	3.71e-06	0.000109	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SOCS1—coronary artery disease	3.7e-06	0.000109	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—S100B—coronary artery disease	3.69e-06	0.000109	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CETP—coronary artery disease	3.66e-06	0.000108	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GCLC—coronary artery disease	3.66e-06	0.000108	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SOCS3—coronary artery disease	3.66e-06	0.000108	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PSMB5—coronary artery disease	3.63e-06	0.000107	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PSMA6—coronary artery disease	3.63e-06	0.000107	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—SDC1—coronary artery disease	3.62e-06	0.000107	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—KITLG—coronary artery disease	3.61e-06	0.000107	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—TGFBR2—coronary artery disease	3.61e-06	0.000107	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—NOS3—coronary artery disease	3.61e-06	0.000106	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PPARG—coronary artery disease	3.59e-06	0.000106	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CTGF—coronary artery disease	3.55e-06	0.000105	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—POMC—coronary artery disease	3.54e-06	0.000104	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—STAT5A—coronary artery disease	3.53e-06	0.000104	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MMP3—coronary artery disease	3.53e-06	0.000104	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GOT2—coronary artery disease	3.51e-06	0.000104	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—HMGCR—coronary artery disease	3.51e-06	0.000104	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—ALB—coronary artery disease	3.45e-06	0.000102	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PSMA6—coronary artery disease	3.42e-06	0.000101	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PSMB5—coronary artery disease	3.42e-06	0.000101	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—APOB—coronary artery disease	3.41e-06	0.000101	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—CXCL8—coronary artery disease	3.39e-06	9.98e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—JAK2—coronary artery disease	3.37e-06	9.93e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—EDN1—coronary artery disease	3.36e-06	9.9e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CTGF—coronary artery disease	3.34e-06	9.85e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CCL5—coronary artery disease	3.33e-06	9.83e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—HMGCR—coronary artery disease	3.31e-06	9.76e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GOT2—coronary artery disease	3.31e-06	9.76e-05	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PTGS2—coronary artery disease	3.3e-06	9.72e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CSF2—coronary artery disease	3.28e-06	9.68e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—FGF1—coronary artery disease	3.28e-06	9.68e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—LPL—coronary artery disease	3.26e-06	9.61e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PLCB1—coronary artery disease	3.23e-06	9.53e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MEF2C—coronary artery disease	3.23e-06	9.52e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—RPS6KB1—coronary artery disease	3.23e-06	9.52e-05	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—ALB—coronary artery disease	3.22e-06	9.5e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ITGB3—coronary artery disease	3.15e-06	9.28e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ABCA1—coronary artery disease	3.13e-06	9.23e-05	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—NOS3—coronary artery disease	3.08e-06	9.09e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—CXCL8—coronary artery disease	3.07e-06	9.06e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PPP2CA—coronary artery disease	3.06e-06	9.02e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PLCB1—coronary artery disease	3.05e-06	8.98e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GOT1—coronary artery disease	3.03e-06	8.94e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GGT1—coronary artery disease	3.03e-06	8.94e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PRKCD—coronary artery disease	3e-06	8.85e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ABCA1—coronary artery disease	2.95e-06	8.7e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—HTR2A—coronary artery disease	2.94e-06	8.66e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—C3—coronary artery disease	2.94e-06	8.65e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GGT1—coronary artery disease	2.86e-06	8.43e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GOT1—coronary artery disease	2.86e-06	8.43e-05	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PTGS2—coronary artery disease	2.82e-06	8.31e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—HIF1A—coronary artery disease	2.8e-06	8.25e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—AGT—coronary artery disease	2.79e-06	8.22e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—LEP—coronary artery disease	2.73e-06	8.05e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—APOE—coronary artery disease	2.73e-06	8.05e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GSTP1—coronary artery disease	2.73e-06	8.03e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—APOA1—coronary artery disease	2.7e-06	7.96e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PPARGC1A—coronary artery disease	2.7e-06	7.96e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—HMOX1—coronary artery disease	2.69e-06	7.92e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—KDR—coronary artery disease	2.68e-06	7.89e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MAPK14—coronary artery disease	2.66e-06	7.84e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CAT—coronary artery disease	2.65e-06	7.82e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ESR1—coronary artery disease	2.61e-06	7.69e-05	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PIK3CA—coronary artery disease	2.58e-06	7.61e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—F2—coronary artery disease	2.58e-06	7.6e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—FN1—coronary artery disease	2.58e-06	7.6e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—APOB—coronary artery disease	2.57e-06	7.59e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GSTP1—coronary artery disease	2.57e-06	7.57e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IL6ST—coronary artery disease	2.57e-06	7.57e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—NFKBIA—coronary artery disease	2.55e-06	7.51e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	2.54e-06	7.5e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—HMOX1—coronary artery disease	2.53e-06	7.47e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GSTM1—coronary artery disease	2.5e-06	7.38e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CAT—coronary artery disease	2.5e-06	7.37e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—KIT—coronary artery disease	2.47e-06	7.27e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—LPL—coronary artery disease	2.46e-06	7.25e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—APOB—coronary artery disease	2.43e-06	7.15e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GPX1—coronary artery disease	2.4e-06	7.07e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—GSK3B—coronary artery disease	2.37e-06	6.98e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GSTM1—coronary artery disease	2.36e-06	6.96e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—POMC—coronary artery disease	2.35e-06	6.92e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CREB1—coronary artery disease	2.35e-06	6.92e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CD36—coronary artery disease	2.34e-06	6.88e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—LPL—coronary artery disease	2.32e-06	6.83e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PPP2CA—coronary artery disease	2.31e-06	6.8e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CCL2—coronary artery disease	2.3e-06	6.77e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IL6R—coronary artery disease	2.29e-06	6.75e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GPX1—coronary artery disease	2.26e-06	6.66e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IGF1—coronary artery disease	2.26e-06	6.66e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—MAPK1—coronary artery disease	2.25e-06	6.62e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—MTHFR—coronary artery disease	2.21e-06	6.52e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CD36—coronary artery disease	2.2e-06	6.49e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PPP2CA—coronary artery disease	2.17e-06	6.41e-05	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PIK3CA—coronary artery disease	2.15e-06	6.33e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SERPINE1—coronary artery disease	2.14e-06	6.32e-05	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—AKT1—coronary artery disease	2.11e-06	6.22e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—AGT—coronary artery disease	2.1e-06	6.2e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—MTHFR—coronary artery disease	2.09e-06	6.15e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—FGF2—coronary artery disease	2.08e-06	6.12e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—APOE—coronary artery disease	2.06e-06	6.07e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—NOS3—coronary artery disease	2.05e-06	6.03e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—APOA1—coronary artery disease	2.04e-06	6e-05	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PIK3CA—coronary artery disease	2.03e-06	5.98e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—JAK2—coronary artery disease	1.99e-06	5.86e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—AGT—coronary artery disease	1.98e-06	5.84e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PIK3CA—coronary artery disease	1.95e-06	5.75e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—APOE—coronary artery disease	1.94e-06	5.72e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—APOA1—coronary artery disease	1.92e-06	5.66e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CXCL8—coronary artery disease	1.82e-06	5.35e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PPARG—coronary artery disease	1.79e-06	5.29e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—POMC—coronary artery disease	1.77e-06	5.22e-05	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—AKT1—coronary artery disease	1.75e-06	5.17e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CASP3—coronary artery disease	1.74e-06	5.12e-05	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PIK3CA—coronary artery disease	1.74e-06	5.11e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—IL6—coronary artery disease	1.73e-06	5.09e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CCND1—coronary artery disease	1.69e-06	4.99e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PPARG—coronary artery disease	1.69e-06	4.99e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—POMC—coronary artery disease	1.67e-06	4.92e-05	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—AKT1—coronary artery disease	1.66e-06	4.89e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MMP9—coronary artery disease	1.64e-06	4.84e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ALB—coronary artery disease	1.61e-06	4.76e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—AKT1—coronary artery disease	1.59e-06	4.7e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—NOS3—coronary artery disease	1.54e-06	4.55e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ALB—coronary artery disease	1.52e-06	4.48e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—VEGFA—coronary artery disease	1.48e-06	4.35e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—NOS3—coronary artery disease	1.45e-06	4.29e-05	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—AKT1—coronary artery disease	1.42e-06	4.18e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PTGS2—coronary artery disease	1.41e-06	4.16e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—TGFB1—coronary artery disease	1.35e-06	3.99e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PTGS2—coronary artery disease	1.33e-06	3.92e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MAPK1—coronary artery disease	1.33e-06	3.91e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PIK3CA—coronary artery disease	1.15e-06	3.4e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IL6—coronary artery disease	1.02e-06	3.01e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—AKT1—coronary artery disease	9.41e-07	2.77e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PIK3CA—coronary artery disease	8.69e-07	2.56e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PIK3CA—coronary artery disease	8.19e-07	2.41e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—AKT1—coronary artery disease	7.1e-07	2.09e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—AKT1—coronary artery disease	6.69e-07	1.97e-05	CbGpPWpGaD
